Oxford Science Enterprises logo

Oxford Science Enterprises

Europe, Oxfordshire, United Kingdom, Oxford

Description

Oxford Science Enterprises (OSE), formerly known as Oxford Sciences Innovation plc, is a distinctive venture firm established in partnership with the University of Oxford. Its core mission is to commercialize the groundbreaking research emerging from the university's world-leading departments by building and scaling innovative companies. OSE operates as an independent investment company, providing capital and strategic support to transform scientific discoveries into viable businesses across various high-growth sectors, ensuring that academic breakthroughs translate into real-world impact and economic value.

Investor Profile

Oxford Science Enterprises has backed more than 160 startups, with 10 new investments in the last 12 months alone. The firm has led 64 rounds, about 40% of its total and boasts 13 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A, Series B rounds (top funding stages).
  • Majority of deals are located in United Kingdom, United States, The Netherlands.
  • Strong thematic focus on Biotechnology, Health Care, Software.
  • Led 4 rounds in the past year.
  • Typical check size: $1.3M – $12.7M.

Stage Focus

  • Seed (41%)
  • Series A (30%)
  • Series B (14%)
  • Series Unknown (8%)
  • Series C (3%)
  • Pre Seed (3%)
  • Convertible Note (1%)
  • Undisclosed (1%)

Country Focus

  • United Kingdom (95%)
  • United States (2%)
  • The Netherlands (1%)
  • Finland (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Software
  • Medical
  • Therapeutics
  • Life Science
  • Information Technology
  • Artificial Intelligence (Ai)
  • Quantum Computing
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Oxford Science Enterprises frequently co-invest with?

Oxford Investment Consultants LLP
Europe, Oxfordshire, United Kingdom, Oxford
Co-Investments: 15
G. K. Goh
Asia, Central Region, Singapore, Singapore
Co-Investments: 5
Lansdowne Partners
Europe, England, United Kingdom, London
Co-Investments: 8
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 7
Oxford University Innovation
Europe, Oxfordshire, United Kingdom, Oxford
Co-Investments: 15
BI
Europe, England, United Kingdom, London
Co-Investments: 5
Future Planet Capital
Europe, England, United Kingdom, London
Co-Investments: 9
IP Group
Europe, England, United Kingdom, London
Co-Investments: 15
University of Oxford
Europe, Oxfordshire, United Kingdom, Oxford
Co-Investments: 17
Parkwalk Advisors
Europe, England, United Kingdom, London
Co-Investments: 22

Which angels does Oxford Science Enterprises often collaborate with?

JB
Europe, Surrey, United Kingdom, Guildford
Shared Deals: 2
AC
Europe, England, United Kingdom, London
Shared Deals: 2
HH
Europe, Cambridgeshire, United Kingdom, Cambridge
Shared Deals: 2
Shared Deals: 1
Fritz Demopoulos
Asia, Singapore
Shared Deals: 1
PF
North America, Massachusetts, United States, Cambridge
Shared Deals: 1
AM
North America, California, United States, San Francisco
Shared Deals: 1
WB
Europe, England, United Kingdom, London
Shared Deals: 1
WM
Europe, England, United Kingdom, London
Shared Deals: 1
David Langer
North America, California, United States
Shared Deals: 1

What are some of recent deals done by Oxford Science Enterprises?

Fractile

London, England, United Kingdom

Fractile is building chips that remove every bottleneck to running large language models at a global scale

AI InfrastructureArtificial Intelligence (AI)HardwareSemiconductor
Series UnknownJan 15, 2026
Amount Raised: $22,500,000
Allos

London, England, United Kingdom

Allos is a solution to prognose, monitor, and treat autoimmune conditions.

Health CareHealth Diagnostics
SeedJan 12, 2026
Amount Raised: $5,000,000
Beacon Therapeutics

Alachua, Florida, United States

Beacon Therapeutics is a biotechnology company that develops treatments to preserve and restore vision for rare and prevalent eye diseases.

BiotechnologyHealth CareLife ScienceTherapeutics
Series CJan 8, 2026
Amount Raised: $75,000,000
Scripta Therapeutics

Oxford, Oxfordshire, United Kingdom

Scripta Therapeutics operates as a bio-tech company.

BiotechnologyMedicalTherapeutics
SeedNov 13, 2025
Amount Raised: $12,000,000
Valink Therapeutics

London, England, United Kingdom

Valink Therapeutics is a health care drug discovery for next-generation cancer treatments.

Health CareTherapeuticsWellness
SeedOct 20, 2025
Amount Raised: $11,800,000
Wild Bioscience

Oxford, Oxfordshire, United Kingdom

Wild Bioscience is a crop improvement company that provides carbon mitigation, yield enhancement, and farm productivity solutions.

AgTechBiotechnologySustainability
Series AOct 16, 2025
Amount Raised: $60,400,414
Kneu Health

London, England, United Kingdom

Kneu Health transforms smart phones into clinical-grade monitors to keep a tab on neurological conditions like Parkinson’s and dementia.

Health CareNeuroscience
SeedOct 9, 2025
Amount Raised: $5,587,254

Oath Surgical operates with distinction, offering our patients, associates, and partners unmatched value and experiences.

Artificial Intelligence (AI)Health CareHospital
Series AOct 6, 2025
Amount Raised: $24,000,000
Ultromics

Oxford, Oxfordshire, United Kingdom

Ultromics develops AI-driven cardiology solutions to assist in cardiovascular disease diagnosis through echocardiography.

Artificial Intelligence (AI)Health CareHealth DiagnosticsMedicalSoftware
Series CJul 31, 2025
Amount Raised: $55,000,000
Navlive

Oxford, Oxfordshire, United Kingdom

NavLive creates instant 2D and 3D models, along with accurate site surveys using user-friendly Scan-to-BIM functionality.

ArchitectureConstructionSmart Building
SeedMay 29, 2025
Amount Raised: $4,442,572

Find More Investors Like Oxford Science Enterprises

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides